Introduction to the National Healthcare Safety Network (NHSN) Richard Rodriguez, MPH Connecticut Department of Public Health 4/9/2014 Thank you to CDC.

Slides:



Advertisements
Similar presentations
HAI Program Update Meredith Kanago, MSPH TDH Statewide CEDEP Meeting 30 April 2014.
Advertisements

SAFE-ITSM STANDARDS.
Facility ID:________________Event#_________________________ *Patient ID:_____________________ Social Security#: __ __ __ - __ __ - __ __ __ __ Secondary.
Antimicrobial Stewardship: an HAI response activity in Connecticut Richard Melchreit, MD HAI Program Coordinator.
World Health Organization TB Case Definitions
Measurement: the why and the what
Abstract Results continued Reference 1 McDonald LC, Coignard B, Dubberke E, et al. Recommendations for Surveillance of Clostridium difficile-Associated.
James Marx, PhD, RN, CIC Broad Street Solutions October 2014.
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Meeting the Challenge of Mandatory HAI Reporting Marcy Maxwell RN, BSN, CIC Dignity Health March 6, 2012.
C. difficile Lab ID Reporting in NHSN Stanley Ostrawski RN, MS, MT(ASCP), CIC Infection Preventionist Consultant.
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Burton Garten Indiana State Department of Health.
Healthcare-Associated Infection (HAI) Prevention
Healthcare-associated Infections and Antibiotic Resistance
NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.
Objectives After this session, the attendee should be able to:
Influenza Vaccination Coverage Among Healthcare Workers – Maine, 2012 Susan E. Manning, MD, MPH, Sara Robinson, MPH, Stephen D. Sears, MD, MPH Maine Center.
HB 197 Barbara W. Bradley, MS, RN, CIC Chief, Bureau of Infectious Disease Control Ohio Department of Health.
Dexanne B. Clohan, MD SVP & Chief Medical Officer HealthSouth November 14, 2014 IRF Quality Measurement: A Physiatrist’s View.
Affordable Care Act Section 3004 Inpatient Rehabilitation Facility Quality Reporting Program Provider Training Caroline D. Gallaher, R.N., B.S.N, J.D.
Presentation to: Georgia Hospital Association Presented by: Matthew Crist, MD, MPH Date: October 31, 2012 The Path to National Healthcare Surveillance.
Healthcare Personnel Safety Component Healthcare Personnel Vaccination Module Influenza Vaccination Summary Ambulatory Surgery Centers National Center.
NHSN Data Submission Requirements 2013 Health Care Excel Cathie Pritchard LPN, RHIT Quality Data Reporting Technologist October 12, 2012.
Long Term Care CDI/MDRO Prevention Collaborative: Connecticut Program Update Richard Melchreit, MD HAI Program Coordinator.
Katherine Allen-Bridson, RN, BSN, MScPH, CIC, Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases.
Measurement: the why, the what, and the how Paula Griswold, MPH Executive Director Massachusetts Coalition for the Prevention of Medical Errors Nora McElroy,
CDI prevention: A call to action for nursing homes
NHSN Reporting for Laboratory-identified Clostridium difficile Infection (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) (Bacteremia) Presentation.
Indiana Healthcare Associated Infection Initiative Kickoff.
1 MÉNARD, MARTIN, AVOCATS THE RIGHT TO SAFE CARE LEGAL ISSUES By: Mtre. Jean-Pierre Ménard, Ad. E.
Background In 2009, the Centers for Disease Control and Prevention (CDC) introduced a module in the National Healthcare Safety Network (NHSN) allowing.
Using and Sharing Findings from Surveillance: Rates, Ratios Proportions, Data Display & OUTBREAKS Russ Olmsted, MPH, CIC
Healthcare Associated Infections in 2014 Acute Care Hospitals Alfred DeMaria, Jr., M.D. Medical Director, State Epidemiologist Bureau of Infectious Disease.
Mary Andrus, BA, RN, CIC Division of Healthcare Quality Promotion
Background In July 2009, New York State (NYS) began using the National Healthcare Safety Network (NHSN) LabID Event module to report facility-wide Clostridium.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
Hospital Outreach Unit: Local public health and HAIs Dawn Terashita MD, MPH Acute Communicable Disease Control Los Angeles County Department of Public.
Piloting HAI Data Collection in Maryland Long Term Care Facilities: Successes and Challenges Elisabeth Vaeth, MPH Epidemiologist, Emerging Infections Program.
OVERVIEW AND COMPLETING THE QUESTIONNAIRES - Part 1 LECTURE 2.
Cohort 1A-C Coaching Call October 1, 2014 Facilitators: Lisa Carhuff Kathy McGowan Joyce Reid.
Applying the NHSN CAUTI Criteria to Case Studies
AHRQ Safety Program for Long-term Care: HAIs/CAUTI Infection Prevention: Surveillance Essentials in Preventing Health Care-Associated Infections How to.
AHRQ Safety Program for Long-term Care: HAIs/CAUTI Infection Prevention: Surveillance Essentials in Preventing Health Care-Associated Infections How to.
AHRQ Safety Program for Long-term Care: HAIs/CAUTI Infection Prevention: Surveillance Essentials in Preventing Health Care-Associated Infections How to.
PREPARING FOR PARTICIPATION IN HALT-2 LECTURE 6. To outline the steps necessary to prepare successfully for the HALT 2013 PPS. LECTURE OBJECTIVES.
Guidance Training (F520) §483.75(o) Quality Assessment and Assurance.
Cohort Coaching Call “Cohort 9” October 15, 2014 Coaches: Tracy Rutland Jean Allred Jan Ratterree Lynne Hall.
Facility ID:Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M*Date of Birth: Ethnicity (specify):Race.
U.S. Strategies to Improve Human Antibiotic Use Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship April 13, 2016 National Center for Emerging.
Purposes of NHSN Participation in the NHSN reflects the individual facility’s need for high quality and timely data on adverse events and adherence to.
Health Facility Compliance Patient Quality Care Unit Division of Regulatory Services Texas Department of State Health Services.
National Hospital Care Survey (NHCS) Acute Coronary Syndrome Study.
*Facility ID:*Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M Other *Date of Birth: Ethnicity (specify):Race.
Facility Information: *Facility Name: __________________________________________________________________ *Main Telephone Number: ( ) ______-____________.
The AHRQ Safety Program for Improving Antibiotic Use
NHSN Reporting for Critical Access Hospitals
Point Prevalence Survey in a Long Term Care Facility, 2016
The AHRQ Safety Program for Improving Antibiotic Use
This is an archived document.
The AHRQ Safety Program for Improving Antibiotic Use
Michelle Charles MSN, RN Karen Vallejo MSN, RN, CIC
Keeping the Glowing Going: Preview of Upcoming HAI Activities in NM
Robin Nettleton MSN RN St. Luke’s Elmore, Mountain Home
APIC Chapter 13 Journal Club
CAH Healthcare Worker Immunizations
Public Health Surveillance
Maryland HCW Influenza Vaccination Survey Highlights
CIC Practice Questions
Presentation transcript:

Introduction to the National Healthcare Safety Network (NHSN) Richard Rodriguez, MPH Connecticut Department of Public Health 4/9/2014 Thank you to CDC for allowing CT-DPH to utilize NHSN training material in the current presentation

Objectives Why use the National Healthcare Safety Network (NHSN) to monitor C.difficile infection (CDI) in long-term care facilities? What is NHSN? How can NHSN help you monitor and track CDI trends over time in your facility?

How NHSN is Being Used in CT Ct healthcare facilities currently use NHSN to fulfill CMS and state reporting mandates Type of facilities currently using NHSN to fulfill mandates  Acute Care Facilities  Long-term Acute Care Facilities  Inpatient Rehabilitation Facilities  Outpatient Dialysis Facilities

Why use NHSN to Monitor CDI? Residents in long term care facilities are at risk of carrying or acquiring C. difficile Infections from C. difficile can be severe, hard to treat, and are associated with increased risk of hospitalization, debility, and death Focused monitoring of C. difficile helps to evaluate trends and changes in its occurrence and related infections in the facility over time Tracking these events can help infection control staff identify problems, and help evaluate the impact of targeted prevention efforts Familiarize yourselves with NHSN before LTC facilities are mandated to use it

NHSN: What is it? Internet-based surveillance system that monitors patient, resident and healthcare personnel safety NHSN maintains data security, integrity, and confidentiality (all data is viewable to CDC) Has capacity for users to share data in a timely manner between facilities or with other entities No fee for participation in NHSN

NHSN: Its Purpose Collects data from a sample of U.S. healthcare facilities to permit valid estimation of :  the magnitude of adverse events (i.e. HAIs)  healthcare process measures such as healthcare personnel influenza vaccine status and infection control adherence rates Data is analyzed and reported to permit recognition of trends

NHSN: Its Purpose Provides facilities with data that can be used for  Local quality improvement activities  Inter-facility comparisons Assists facilities in developing surveillance and analysis methods that permit  Timely recognition of problems  Prompt intervention with appropriate measures Conduct collaborative research studies with members

Authority and Confidentiality for NHSN Public Health Service Act (42 USC 242b, 242k, and 242m(d)) Confidentiality protection  Sections 304, 306, 308(d) of the PHS Act “The information contained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306, and 308(d) of the Public Health Services Act (42 USC 242b, 242k, and 242m(d)).”

NHSN Structure Patient Safety Healthcare Personnel Safety Biovigilance Long-term Care Facility Components of NHSN

NHSN Components for Long-term Care Facilities Currently, LTCF can enroll in two NHSN Components  Long-term Care Facility Component  Healthcare Personnel Safety Component

Long-term Care Facility Healthcare associated infection Laboratory identified (Lab ID) event Prevention process measures Modules of the LTCF Component

Long-term Care Facility Component Modules Healthcare Associated Infection Module  Urinary tract infection events (both catheter- and non catheter-associated) Laboratory Identified (Lab-ID) Event Module  C. difficile infections (CDI)  Multidrug-resistance Organisms (MDRO) Preventions Process Measures Module  Hand hygiene  Gown and glove use

Purpose of Lab-ID Event Reporting for CDI To calculate proxy measures for CDI events, exposures, and healthcare acquisition This method is based solely on laboratory data and limited resident admissions/transfer data  This includes results of testing performed on residents while at the facility Clinical evaluation of resident is not required, and therefore this surveillance option is less labor intensive

Reporting Requirements Facility survey  Completed once a year  Collects information on facility characteristics Facilities must indicate Lab-ID event surveillance in the Monthly Reporting Plan for LTCF Surveillance must be reported for at least 6 consecutive months to provide meaningful measures CDI surveillance should be performed facility-wide

Reporting Requirements (continued) Numerator data  Collect and report each CDI event that meets the Lab-ID Event definition Denominator data  Resident-days each month  Resident admissions each month

Form for Data Collection One form per MDRO or CDI Event “

Data Entry in NHSN Data entered into NHSN are available to the facility and CDC as soon as they are saved  No “transmission” lag Data can be edited after they are saved Records can be deleted

CDI Definitions for Lab-ID Event C. difficile positive laboratory assay: A positive result for a laboratory test detecting presence of either of the following:  C. difficile toxin A or B (e.g., enzyme immunoassay or EIA test), OR  toxin-producing C. difficile organism detected in the stool specimen by culture or other laboratory means (e.g., nucleic acid amplification testing by polymerase-chain reaction, or PCR). Duplicate C. difficile positive assay: Any C. difficile positive laboratory test from the same resident following a previous C. difficile positive test within the past 2 weeks

CDI Definitions (continued) CDI Lab-ID Event: All non-duplicate C. difficile positive laboratory assays obtained while a resident is receiving care in the LTCF  Lab results from outside facilities, before a resident’s admission, should not be included in Lab-ID event reporting  It is helpful to keep a log of all the positive C. difficile tests sent from your facility so you can track duplicate results to ensure they are not incorrectly entered as CDI Lab-ID Events

CDI Definitions (continued) Once CDI Lab-ID Events are entered into NHSN, they are further categorized by the NHSN system:  Incident CDI Lab-ID Event: The first Lab-ID Event ever entered or a subsequent Lab-ID Event entered > 8 weeks after the most recent Lab-ID Event reported for an individual resident  First or new infections that are unrelated to previous infections  Recurrent CDI Lab-ID Event: Any Lab-ID Event entered > 2 weeks and ≤ 8 weeks after the most recent Lab-ID Event reported for an individual resident  Infections that recur after having been thought resolved

Lab-ID Event Categorization Based on data provided for the Lab-ID Event, each event is categorized by NHSN as  Community-onset (CO) Lab-ID Event: Date specimen collected ≤ 3 calendar days after current admission to the facility (i.e., days 1, 2, or 3 of admission)  Long-term Care Facility-onset (LO) Lab-ID Event : Date specimen collected > 3 calendar days after current admission to the facility (i.e., on or after day 4)

Lab-ID Event Categorization (continued) LO Events are further sub-classified  Acute Care Transfer-Long-term Care Facility-onset (ACT-LO): LTCF-onset (LO) Lab-ID event with specimen collection date ≤ 4 weeks following date of last transfer from an Acute Care Facility (Hospital, Long-term acute care hospital, or Acute inpatient rehabilitation facility only) Categories are based on the date of current admission to facility and the date specimen collected

What Information Can you Get from NHSN? Total CDI Rate (per 10,000 resident-days) Long-term Care Facility-onset (LO) Incidence Rate (per) 10,000 resident-days Percent that is Community-onset (CO) Percent that is Long-term Care Facility-onset (LO) and CDI LO that is Acute Care Transfer (ACT LO) Percent that is Recurrent CDI

Using Your Data Data can be used to characterize CDI in your facility Data can be looked at over time for trends Data can be used to evaluate interventions

NHSN Website

NHSN Website (continued)

NHSN Website

Contact Information Richard Rodriguez, MPH Epidemiologist Healthcare Associated Infections Program Infectious Disease Section Connecticut Department of Public Health Tel: (860) Fax: (860)